Neogen Corporation (NASDAQ: NEOG) is a Healthcare company (Medical - Devices) with a market capitalization of $2.4B. The Maz Rating grades it against the other companies in its sector.
Neogen Corporation's current Maz Rating and its five factor grades are for members: log in to see them.
At $10.91, Neogen Corporation trades at 2.7x sales and 1.1x book value, with an EV/EBITDA of 28.3. Over the last twelve months it generated about $887M of revenue and a net loss of $55M. It runs a gross margin of 47.4%, an operating margin of -0.8% and a net margin of -6.3%. It shows return on equity of -2.7%, return on invested capital of -0.2% and a free cash flow yield of 2.1%. On the balance sheet: a debt-to-equity ratio of 0.37 and a current ratio of 3.90. Over the past 52 weeks the share price ranged from $5.37 to $14.26, with a beta of 1.86.
Neogen Corporation does not currently pay a dividend.
11 Wall Street analyst ratings cover the stock: 5 Buy, 5 Hold and 1 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.